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INTRODUCTION
Health care policies for the population are a challenge faced 
by many countries, including Brazil. The United States are cur-
rently facing a health crisis, with cumulative costs summing 
up two trillion dollars per year, the equivalent to 16% of the 
country Gross Domestic Product. Resources are scarce and 
finite, either in human, time, financial, physical and structural 
terms; and all choices must be made every days.1 Therefore, 
the need for studies to assess the economic impact of health 
initiatives has recently grown.2
The economic evaluation is important for decision-making re-
garding the allocation of resources, aiming greater efficiency 
and effectiveness in its use.3 Without careful analysis of all 
aspects involved in an intervention, including costs and conse-
quences, wrong decisions may eventually be adopted in prac-
tice.2 Research in the field of quality of life have led clinicians, 
scientists, economists and managers to become interested 
by the impact brought by new technologies in terms of health 
status and costs for the health systems.4
The development of science and technology has improved 
the effectiveness of diagnostic and therapeutic methods. This, 
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ABSTRACT
The aim of this study was to describe concepts of health econo-
mics in order to update and provide the orthopedic practitioner 
decision making parameters based on preferences. Four ba-
sic types of studies of economical evaluation were presented 
(cost minimization analysis, cost-benefit, cost-effectiveness and 
cost-utility), as well as the origin, the concept, advantages and 
disadvantages of using QALY and utility. It was discussed the 
importance of costs and of SF-6D, an instrument able to get 
through the utility data from the Medical Outcomes Study 36-item 
Short Form Health Survey (SF-36). Physicians, especially ortho-
pedic practitioners, are increasingly using technologies which are 
progressively expensive, thus, they should be able to understand 
health economics concepts, the importance of utility in clinical 
decision making process and economic analysis in health.
Keywords: Quality of life. Quality-adjusted life years. Cost-
-benefit analysis.
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in turn, increases life expectance, but increases the costs of 
health systems.4 The orthopedist is seen as a consumer of 
expensive, fragile and difficult to maintain technologies being 
massively harassed by advertisements, which invariably leads 
to a cost which is transferred to customers, leveraging social 
and individual cost of orthopedic medicine to ever higher and 
elitist levels.5
Decision making that are based on preferences for health sta-
tes, along with the economic analysis focused on the patient’s 
perspective, improve the distribution of finite resources in the 
face of a growing and increasingly challenging demand.
This study aims to contextualize these principles that should be 
understood, studied and used by orthopedists.
Types of economic assessment studies 
There are four basic types of studies for economic evaluation: 
cost minimization analysis, cost- benefit, cost-effectiveness and 
cost-utility. The costs of health interventions are expressed in 
monetary units. Cost-minimization indicates which alternative 
has the lowest cost. Cost- benefit generate a quotient between 
resources spent and acquired benefits.2
The analysis of cost- effectiveness enables full economic eva-
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luation in health, with effects expressed in clinical and epide-
miological units.6 In these studies, the effectiveness can be as-
sessed through quality of live instruments.7 Cost- effectiveness 
also allows checking which strategy is more effective.8
Cost-utility analysis establishes a relationship between the 
amount spent and the quality and quantity of life gains. A cost-
-utility analysis refines the cost-effectiveness outcome, it allows 
to compare any types of health interventions and their effects, 
measured in Quality-adjusted life years (QALY).6 This assessment 
can show alternatives to maximize achieving the target within a 
minimum budget.8 For an instrument be able to provide objective 
data for cost-utility assessment, it must be based on preferences.
The perspective of the analysis is the point of view from which 
the analysis is conducted, and it may be the patient’s perspec-
tive, the program’s perspective (a service provider), the payer’s 
perspective (a health insurance plan) or the society’s perspec-
tive. Cost-utility studies can be seen as a cost-effectiveness 
economic analysis conducted from the patient’s perspective 
that takes as a parameter the QALYs’ clinical effectiveness.4
Preference as a parameter for decision making
It is important that the physician is able to measure the per-
ception of the patient to assess the benefit of his interventions. 
Current medicine is not only concerned with the objective data 
of a medical intervention, but also with the patient’s opinion 
about the procedure he underwent. The assessment of quality 
of life and its domains is difficult to perform, since these con-
cepts include subjective elements.
By the need to assess these subjective questions arose inde-
xes, instruments, or indicators (questionnaires with scores) able 
to measure and compare these aspects anywhere in the world. 
Since the validation of various questionnaires until demons-
trating their efficiency, the scientific community increasingly 
seeks to assess satisfaction and patient response to different 
situations and interventions in medicine.
A large number of instruments, methods and techniques have 
been proposed to assess the quality of life and its compo-
nents of patients with various diseases. These instruments 
can be divided into generic and specific. Generic are those 
applicable to a wide variety of people because they inclu-
de aspects of function, dysfunction, and emotional distress. 
Generics have two subcategories, developed to measure all 
important aspects of quality of life related to health (health 
profile) and those that reflect patient preferences for a specific 
health condition or “utility”.
There is a tendency that studies based on patient preferences 
are used in economic decisions and resource distribution.4 
There are two types of preferences: utility or usefulness, which 
is obtained under conditions of uncertainty, and value, which 
is obtained under conditions of certainty.1
Utility
Utility is a specific type of preference, measured under condi-
tions of uncertainty, according to the paradigm established by 
von Neumann-Morgenstern.4 It represents the soundness of 
the preference of an individual under conditions of uncertainty 
that is represented in numerical form from zero to one, where 
zero corresponds to death and one perfect health in the space 
of one year.
Utilities are obtained by individual values  and may represent a 
group, by the sum of measurable and comparable individual 
utilities.9 The advantages of obtaining utility: being based on 
preferences, it enables the calculation of QALY, allows compa-
rison of different interventions and structure the tree decision.
Utility can be obtained directly or indirectly. There are basically 
three well-established techniques for the direct measurement of 
utility (i.e., that argues the individual directly on his preference).10,11 
It consist of performing the valuation (weights system) of a large 
and representative sample of the normal population. They are: 
the choice by chance (Standard Gamble), the choice by time 
(trade-off time) and the visual analogue scale (VAS).
The choice by chance (Standard Gamble) is the most accurate 
method of measuring preference.1 The only technique capable 
of capturing the utility-type preference is the choice by chan-
ce, also known as true utility. The other techniques capture 
the value type preferences. The Standard Gamble have been 
recommended in studies reviewing the different approaches to 
the measurement of preferences.12
It asks respondents to choose between two alternatives. In 
one of the alternative it is offered an intermediary state of he-
alth (e.g., a chronic low back pain), under certainty conditions. 
Alternatively, two health statuses are offered in condition of 
uncertainty in case the patient undergoes a therapeutic pro-
cedure: a state of health would be the best possible (with a P 
probability likely to occur) and it would be the worst case, for 
example death (with probability 1-P).
This measurement is necessary to determine the indifference 
point p* (point at which the patient is indifferent between tre-
atment A or B), because this indifference point p* is the utility 
that the patient attributed to his current health status in a scale 
ranging from 0 to 1.
The choice by time (time trade-off) measures the value type 
preference (in certain conditions) and utility that is considered 
false. Two options for conducting in certainty conditions are 
given, for the patient to decide facing a chronic disease. The 
patient must answer how many years of life he is willing to give 
in exchange for avoiding a particular chronic condition.
The time trade-off method is a practical alternative to the Stan-
dard Gamble.13 The values  obtained by these techniques cor-
respond to preferences for different health status in the general 
population, specific for each region.
The visual analogue scale (VAS) also measures the value type 
preferences (in certainty conditions). A line is drawn on one end 
equivalent to, while the other extremity equals one. The value 
one can correspond to the best possible health status, and zero 
the worst possible (e.g., death).
Direct preference measurements are generally complex, time-
-consuming, costly, and are conducted with the assistance of 
visual resources. In order to obtain the valuation of a normal 
population, a very large sample, time, human and financial re-
sources are needed.14 The biggest cost for obtaining valuations 
of health status is related to data collection.
The cognitive ability, aversion to risk and numerical skills can 
affect the measurement by Standard Gamble, an effect known 
as construct irrelevant variance. Still, these tools have been 
considered as the most suitable for the cost-utility analyzes, 
due to be more theoretical than based on facts.12
The utilities can be measured indirectly through questionnaires 
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with multi-attribute systems for various health status based on 
preferences.  Among the best known instruments are: Quality of 
Well-Being Scale, Health Utilities Index (HUI),  EuroQol-5D, and 
the Short-Form 6 Health Survey Instrument (SF-6D).15
One way to test the properties of indirect measurements con-
sists in administering an indirect method in conjunction with a 
direct method of preferences valuation, such as Time Trade Off 
or Standard Gamble, and to examine the degree of convergen-
ce between them.
In Brazil, the congruence between the indirect methods (based 
on questionnaires) and the direct methods was tested, and 
the method that had the highest number of significant correla-
tions was the SF -6D,15 being also the only one that correlated 
significantly with the Standard Gamble technique.16 SF -6D is 
derived from the world’s most widely used generic instrument 
for assessing quality of life, Medical Outcomes study 36-item 
Short Form Health Survey. SF - 36 has a multitude of data 
available in the literature and has been translated, adapted and 
validated for use in Brazil.16
Another way to test the stated preferences is to analyze the 
degree of convergence between the values generated by di-
fferent indirect measures of choice, such as SF -6D, EQ- 5D or 
HUI.11 For the cost-effectiveness/utility analysis,  indirect me-
asures have been preferred because they allow in a fast and 
objective manner the use of social values , obtained throughout 
the community.
Quality-adjusted life years (QALy)
The concept of QALY was developed in the 1970s from studies 
on chronic renal failure.17 However, the term “quality-adjusted 
life years” (QALY) was first used only in 1976. Currently it is 
interpreted as the result of merging of dimensions quality and 
quantity of life, expressed in the form of utility.9
An extensive review published in 1992 included 51 economic 
evaluations using QALY as a measure of outcome.18 Still, QALY 
outcome raised doubts until after 1996, when convincing stu-
dies about its effectiveness emerged, and it has become widely 
accepted as a reference standard in economic studies.3
QALY has not been designed for decision making for a single 
patient, although sometimes it has been placed on clinical deci-
sion analysis. It is based on the premise that individuals change 
their health status over time and each health status has a value.
QALY, as a reference unit , expressed in the form of utility, can 
be used for cost-utility analyzes in health, because it provides 
a standard measure to compare disease and programs in as-
sessment to incorporate health technology.4 The great advan-
tage of this approach is that it provides a standard measure to 
compare diseases and programs in evaluations to incorporate 
health technology.
Currently, QALYs are used in most economic evaluations by 
many regulatory agencies, which have made the cost-effective-
ness assessment as part of their process of decision making. 
United States (U.S. Panel on Cost Effectiveness in Health and 
Medicine) and Great Britain (Institute of Health and Clinical 
Excellence, NICE) have endorsed the conventional use of QALY 
as standardized method to promote comparative cost -effecti-
veness of different health interventions.
Some limitations of QALY would be prejudice towards older pe-
ople, to give low priority to those patients who are responsible 
for their diseases, giving highest priority to patients who have 
dependents, be benevolent towards patients from lower social 
class (with exceptions for male subjects), and have no prefe-
rence as to the distribution of benefits, unless they are small, 
where the preference falls into the situation that it is better to 
give it to a few people.
Regardless of their methodological controversies the study of 
cost-effectiveness, cost-utility, QALY and utility are important 
allies for economic evaluation of health technology and their 
principles should be understood by health administrators.
DISCUSSION
The managerial knowledge of costs by health professionals, 
especially physicians, is strategic to the development of suc-
cessful cost system and for its economic analysis factor. Ho-
wever, the use of economic evaluations in surgical procedures 
is still scarce and perhaps this is due to the training deficiency 
of the surgeon.19
Studies of cost-effectiveness and in particular cost-utility have 
been growing worldwide, often sponsored or supervised by 
government agencies, in order to guide the manager regar-
ding the allocation of resources.3 Mistakenly, the terms cost 
-effectiveness and cost utility have been used interchangeably, 
although having different concepts.7
Authors argue that the cost-effectiveness of an intervention 
simply mean that, when comparing this intervention to another 
one similar, this or that would be more efficient or would require 
less investment for the same final outcome.14 Assessment of 
cost-effectiveness have been established as the predominant 
valuation techniques in health economics from 1979 being more 
used to assess diagnostic tests and cost-benefit evaluations  in 
preventive interventions.14
Much of the studies cost-benefit and cost-effectiveness is 
achieved with medication, due to sponsorship of pharmaceuti-
cal laboratories. Conducting a systematic review/meta-analysis 
should be a key step in the study of cost-effectiveness. These 
are additional reasons for the scarcity and difficulty in perfor-
ming these studies by surgeons.
The cost-effectiveness and cost utility analysis were included 
among the top five references to resource allocation by directors 
of private health plans, although they are not as used by resour-
ces managers.14 Therefore, the economic evaluation in health has 
a prominent role and requires managers facing new challenges 
in the ongoing quest for efficiency and effectiveness of activities.
Despite criticism, cost analyzes try to bring more efficiency 
in resource allocation. The limitation of resources used in the 
provision of medical care and the increasing demand of health 
needs justify studies and practices in this area. This diversity of 
opinions about the cost analysis is understandable and perfec-
tly justifiable, since it does not seem possible that in such a vast 
field it can exist as an instrument to satisfy all authors, enabling 
the achievement of desired results in any kind of study.10
One of the largest studies of limiting costs is a difficult gene-
ralization to other countries. The difference between currency 
values, prevalence and odds between countries, especially 
when comparing developed countries to developing countries, 
limits the applicability of these studies.20 Therefore, it is impor-
tant to perform analyzes within Brazil, with data reflecting the 
country’s reality.
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Although most health expenditures in Brazil come from Supple-
mentary medicine, approximately 75 % of the population depen-
ds exclusively on the public health care system.20 Resources 
from SUS (Brazilian Unified Health System) represent a signifi-
cant portion of public hospitals financing and its by-procedure 
pay chart does not allow full coverage of the costs of a hospital. 
Is has been estimated in 1997 that each hospital exceeds on a 
daily basis, on average, 60% of the amount provided by SUS.21
In fact, the amount paid by SUS reflects the reality of Brazil, a 
large country with large distortions. On the one hand, there is 
low pay for basic medical procedures and medical fees. On the 
other hand, suppliers of orthopedic implants, stents and image 
tests are well paid. This distortion could contribute to indications 
of questionable treatments and surgeries.
For these reasons, in Brazil, cost studies and economic analyzes 
that give special attention to procedures performed by the public 
health care system should be encouraged in order to assist SUS 
managers in the proper allocation and distribution of resources.
Utility, as part of a cost and economic analysis study should be 
obtained more frequently to evaluate medical interventions. A 
special relevant importance is presented by SF- 6D, an instru-
ment able to get through the use of data from SF-36. SF -6D has 
had its measure properties tested and validated for use in Brazil 
in its original format, and it is the only derivative of Standard 
Gamble, considered the most consistent in health analyzes.16
FINAL CONSIDERATIONS
However, for this to happen it is necessary that physicians 
better understand some economics concepts, as well as the 
importance of utility as a tool capable of accomplishing the 
structuring of clinical decision analysis and economic analysis 
in health. The orthopedist has a prominent position in these 
cases, due to the gradual and progressive use of expensive 
technologies, and as a commercial target of large enterprises.
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